Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex reversal and postoperative residual block in elderly patients undergoing laparoscopic cholecystectomy
ACTRN12615000758505Phase 4Completed
- Sponsor
- Emine Yazar
- Start
- May 2012
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of Sugammadex in Postoperative residual curarization (PORC) (2 arms), sponsored by Emine Yazar. Primary endpoints: Incidence of postoperative residual curarization and Rate of reintubation. Started May 2012; status: completed.
02
Drugs
Sugammadex
03
Conditions
Postoperative residual curarization (PORC)
Beyond the preview
Go deeper on ACTRN12615000758505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000758505.